Author(s): Garg A, Wertenteil S, Baltz R, Strunk A, Finelt N
The prevalence of Hidradenitis Suppurativa (HS) in the pediatric population is unknown. We sought to establish standardized overall as well as gender-, age-, and race-specific prevalence estimates of HS among children and adolescents in the United States. We performed a cross-sectional analysis in a heterogeneous sample of 55 million patients across all census regions. We identified 1,240 HS patients in whom the ratio of girls to boys was 3.8:1. Almost all (96.8%) HS patients were ≥10 years of age. Overall HS prevalence was 0.028%, or 28.1 (95% CI 26.5-29.7) per 100,000 children and adolescents. Standardized prevalence was higher in girls [44.6 (95% CI 41.8-47.5) per 100,000], in patients aged 15-17 years [113.7 (95% CI 106.4-121.4) per 100,000], and among African Americans [78.7 (95% CI 71.0-86.9) per 100,000]. Highest prevalence of HS was observed among female adolescents aged 15-17 years who were African Americans [525.1 (95% CI 459.4-597.5) per 100,000] and biracial [253.2 (95% CI 121.4-465.6) per 100,000]. Patients with HS who went undiagnosed were not captured, and as such prevalence estimates may be underestimated. HS appears to be a post-pubertal disease which disproportionately afflicts girls and African Americans in the pediatric population.
Dermatology Journal and/or Publisher
Journal Name: The Journal of investigative dermatology
Journal Abbreviation: J. Invest. Dermatol.
Journal Date Published:
National Center for Biotechnology Information
Article Source: http://www.ncbi.nlm.nih.gov/pubmed/29660301
Lasted Revision: 2018-04-16
Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).
Tags: Children Family Population Studies Prevalence